MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis

TSX:MDA • CA55293N1096

38.86 CAD
+0.47 (+1.22%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MDA. MDA was compared to 13 industry peers in the Aerospace & Defense industry. Both the profitability and the financial health of MDA get a neutral evaluation. Nothing too spectacular is happening here. MDA is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make MDA suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year MDA was profitable.
  • In the past year MDA had a positive cash flow from operations.
  • MDA had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years MDA had a positive operating cash flow.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of MDA (3.15%) is worse than 69.23% of its industry peers.
  • MDA has a better Return On Equity (8.24%) than 84.62% of its industry peers.
  • MDA has a Return On Invested Capital of 5.12%. This is in the lower half of the industry: MDA underperforms 61.54% of its industry peers.
  • MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 9.34%.
  • The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROIC 5.12%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • MDA has a Profit Margin of 7.40%. This is comparable to the rest of the industry: MDA outperforms 46.15% of its industry peers.
  • In the last couple of years the Profit Margin of MDA has grown nicely.
  • MDA has a worse Operating Margin (9.86%) than 61.54% of its industry peers.
  • In the last couple of years the Operating Margin of MDA has grown nicely.
  • MDA has a Gross Margin of 24.62%. This is in the better half of the industry: MDA outperforms 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of MDA has declined.
Industry RankSector Rank
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
  • The number of shares outstanding for MDA has been increased compared to 1 year ago.
  • The debt/assets ratio for MDA has been reduced compared to a year ago.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.79, we must say that MDA is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.79, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
  • MDA's Debt to FCF ratio of 0.92 is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.31, MDA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Altman-Z 1.79
ROIC/WACC0.57
WACC9.05%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of MDA (0.55) is worse than 84.62% of its industry peers.
  • MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.54, MDA is in line with its industry, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.54
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.25% over the past year.
  • MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
  • MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.77%.
  • The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%

3.2 Future

  • Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.72% on average per year.
  • MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.84% yearly.
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 34.39, which means the current valuation is very expensive for MDA.
  • Based on the Price/Earnings ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
  • The average S&P500 Price/Earnings ratio is at 27.05. MDA is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 25.15, which means the current valuation is very expensive for MDA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, MDA is valued at the same level.
Industry RankSector Rank
PE 34.39
Fwd PE 25.15
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 69.23% of the companies in the same industry are cheaper than MDA, based on the Enterprise Value to EBITDA ratio.
  • MDA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDA is cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.52
EV/EBITDA 19.21
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MDA's earnings are expected to grow with 35.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y48.58%
EPS Next 3Y35.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MDA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA SPACE LTD

TSX:MDA (2/25/2026, 7:00:00 PM)

38.86

+0.47 (+1.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14
Earnings (Next)03-05
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.91B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts80
Price Target46.98 (20.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)15.3%
PT rev (3m)14.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 34.39
Fwd PE 25.15
P/S 3.32
P/FCF 10.52
P/OCF 6.67
P/B 3.69
P/tB N/A
EV/EBITDA 19.21
EPS(TTM)1.13
EY2.91%
EPS(NY)1.55
Fwd EY3.98%
FCF(TTM)3.69
FCFY9.5%
OCF(TTM)5.82
OCFY14.99%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.33
PEG (5Y)N/A
Graham Number16.36
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROCE 7.1%
ROIC 5.12%
ROICexc 5.66%
ROICexgc 60.4%
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
FCFM 31.5%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Debt/EBITDA 1.55
Cap/Depr 226.87%
Cap/Sales 18.19%
Interest Coverage 9.36
Cash Conversion 277.94%
Profit Quality 425.55%
Current Ratio 0.55
Quick Ratio 0.54
Altman-Z 1.79
F-Score6
WACC9.05%
ROIC/WACC0.57
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A

MDA SPACE LTD / MDA.CA FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 5 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 4 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.


What is the profitability of MDA stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


What is the financial health of MDA SPACE LTD (MDA.CA) stock?

The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.


What is the earnings growth outlook for MDA SPACE LTD?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.